Dr. Hazen Honored with Distinguished Scientist Award

Stanley Hazen, MD, PhD, chair of the Department of Cellular & Molecular Medicine and section head of Preventative Cardiology & Rehabilitation in the Miller Family Heart & Vascular Institute, was named a Distinguished Scientist for 2017 by the American Heart Association (AHA). He is the first Cleveland Clinic staff physician to receive this honor.

The Distinguished Scientist designation is awarded to AHA/American Stroke Association members who have made extraordinary contributions to cardiovascular and stroke research. Dr. Hazen is recognized for his cutting-edge research into how the microbiome affects heart and metabolic health.

Dr. Hazen has contributed an unparalleled level of understanding to the field about how a person's diet and gut bacteria affect health and contribute to disease. Among his most seminal discoveries, Dr. Hazen demonstrated for the first time that gut microbial pathways are linked to cardiovascular disease and metabolic diseases including atherosclerosis, thrombosis, heart failure and chronic kidney disease. Most recently, he showed that using therapeutics to interfere with some of these pathways can help prevent diet-dependent atherosclerosis.

As both a basic scientist and practicing physician, Dr. Hazen's research—which has catalyzed the development of diagnostic tests and therapeutic approaches for treating and preventing cardiovascular diseases and metabolic disorders—is a great example of transforming discoveries from the lab bench into improved methods of clinical care at the patient bedside.

Dr. Hazen has received numerous other awards, including election to the American Federation for Medical Research, the American Society for Clinical Investigation, the Association of American Physicians and the National Academy of Medicine. He is also a fellow of the American Association for the Advancement of Science.

Dr. Hazen holds the Jan Bleeksma Chair in Vascular Cell Biology and Atherosclerosis.